共 50 条
- [1] Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina [Letter] DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 3725 - 3726
- [2] Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina [Response to Letter] DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 3989 - 3990
- [3] Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 2135 - 2146
- [4] Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 2911 - 2912
- [10] Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (01): : 22 - 31